港股異動 | 康哲藥業漲5.55% 擬收購一家醫學美容專業公司
格隆匯12月9日丨康哲藥業(00867.HK)漲5.55%,報12.56港元,總市值309億港元。康哲藥業發佈公吿,於2021年12月8日,集團通過公司附屬公司-皮膚醫美業務公司(康哲美麗)向若干獨立第三方賣方收購一家醫學美容專業公司上海旭俐醫療器械有限公司的100%股權。收購事項完成後,目標公司成為公司的附屬公司,其業績及資產與負債將合併入集團的賬目內。目標公司專注於醫美產品領域,紮根醫美行業中上游產業鏈,集研發、生產、銷售、定製代工於一體。收購事項符合集團向醫美領域持續發展的戰略。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.